Muntlig fråga om Säkerhets- och utvecklingscentret för läkemedelsområdet Fimea (Stefan Wallin sv)

This procedure involves an oral question submitted to the Finnish Parliament regarding the operations of Fimea, the national agency responsible for pharmaceutical safety and development. It focuses on how the agency's activities and organizational structure are managed. The inquiry specifically addresses concerns regarding regionalization, staffing, and regional policy as they relate to the agency's functions and its impact on the pharmaceutical sector in Finland.